- Home
- OVID vs NNVC Comparison
OVID vs NNVC Comparison
Compare OVID & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVID
- NNVC
- Stock Information
- Founded
- OVID 2014
- NNVC 2005
- Country
- OVID United States
- NNVC United States
- Employees
- OVID N/A
- NNVC N/A
- Industry
- OVID Biotechnology: Pharmaceutical Preparations
- NNVC Biotechnology: Pharmaceutical Preparations
- Sector
- OVID Health Care
- NNVC Health Care
- Exchange
- OVID Nasdaq
- NNVC Nasdaq
- Market Cap
- OVID 20.6M
- NNVC 24.4M
- IPO Year
- OVID 2017
- NNVC N/A
- Fundamental
- Price
- OVID $0.31
- NNVC $1.44
- Analyst Decision
- OVID Strong Buy
- NNVC
- Analyst Count
- OVID 4
- NNVC 0
- Target Price
- OVID $3.13
- NNVC N/A
- AVG Volume (30 Days)
- OVID 969.8K
- NNVC 252.4K
- Earning Date
- OVID 08-12-2025
- NNVC 05-15-2025
- Dividend Yield
- OVID N/A
- NNVC N/A
- EPS Growth
- OVID N/A
- NNVC N/A
- EPS
- OVID N/A
- NNVC N/A
- Revenue
- OVID $548,000.00
- NNVC N/A
- Revenue This Year
- OVID N/A
- NNVC N/A
- Revenue Next Year
- OVID $5.32
- NNVC N/A
- P/E Ratio
- OVID N/A
- NNVC N/A
- Revenue Growth
- OVID 15.61
- NNVC N/A
- 52 Week Low
- OVID $0.24
- NNVC $0.94
- 52 Week High
- OVID $1.47
- NNVC $2.55
- Technical
- Relative Strength Index (RSI)
- OVID 52.32
- NNVC 48.48
- Support Level
- OVID $0.29
- NNVC $1.25
- Resistance Level
- OVID $0.32
- NNVC $1.54
- Average True Range (ATR)
- OVID 0.03
- NNVC 0.09
- MACD
- OVID 0.00
- NNVC -0.03
- Stochastic Oscillator
- OVID 50.50
- NNVC 54.41
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.